Division of Nephrology, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Kidney360. 2024 Aug 1;5(8):1178-1185. doi: 10.34067/KID.0000000000000511. Epub 2024 Jul 15.
Shorter measured GFR protocols are accurate and precise compared with the reference standard measured GFR protocol in patients with preserved GFR. These shorter protocols can potentially improve the adoption of GFR measurement more widely by reducing procedural time and cost.
Measured GFR (mGFR) using exogenous tracers is recommended in a number of settings. Plasma one-compartment multisample protocols (MSPs) are the most commonly used, with iohexol being the dominant tracer. The accuracy of MSPs has mostly been evaluated in the setting of reduced GFR where delayed initial and final samples are recommended. Much less is known about MSPs when GFR is not decreased, and the default protocol tends to include initial sampling at 120 minutes and final sampling at 240 minutes after iohexol injection. The recent Kidney Disease Improving Global Outcomes 2024 Clinical Practice Guideline for the Evaluation and Management of CKD includes research recommendations for the development of shorter more efficient mGFR protocols. The objective of this study was to assess the performance of shorter MSPs with earlier initial (60 and 90 minutes) and final (150, 180, and 210 minutes) sampling times in individuals with preserved GFR. Reference mGFR (R-mGFR) was calculated using five samples collected between 120 and 240 minutes.
Four different combinations of shorter sampling strategies were investigated. Performance was evaluated using measurements of bias, precision, and accuracy (P2, P5, and mean absolute error).
The mean R-mGFR of the 43 participants was 102.3±13.7 ml/min per 1.73 m. All shorter mGFRs had biases <1 ml/min per 1.73 m and mean absolute error <1.6 ml/min per 1.73 m. All shorter mGFRs were within 5% of the R-mGFR, and the majority were within 2%.
These results demonstrate that shortening the mGFR procedure in individuals with preserved GFR provides similar results to the current standard while significantly decreasing procedure time.
与参考标准测量肾小球滤过率(GFR)相比,保留 GFR 的患者中较短的测量 GFR 方案更准确和精确。这些较短的方案可以通过减少程序时间和成本,潜在地提高 GFR 测量的广泛采用。
在外源性示踪剂的使用中推荐测量 GFR(mGFR)。单室多样本方案(MSP)是最常用的方法,其中碘海醇是主要的示踪剂。MSP 的准确性主要在 GFR 降低的情况下进行评估,其中推荐延迟初始和最终样本。当 GFR 没有降低时,对 MSP 知之甚少,默认方案往往包括在碘海醇注射后 120 分钟进行初始采样和 240 分钟进行最终采样。最近的肾脏病改善全球结局 2024 临床实践指南包括了开发更短、更有效的 mGFR 方案的研究建议。本研究的目的是评估较短的 MSP 在保留 GFR 的个体中更早的初始(60 和 90 分钟)和最终(150、180 和 210 分钟)采样时间的表现。参考 mGFR(R-mGFR)是通过在 120 到 240 分钟之间收集的五个样本计算得出的。
研究了四种不同的较短采样策略组合。使用偏差、精度和准确性(P2、P5 和平均绝对误差)的测量来评估性能。
43 名参与者的平均 R-mGFR 为 102.3±13.7 ml/min/1.73 m。所有较短的 mGFR 偏差都<1 ml/min/1.73 m,平均绝对误差<1.6 ml/min/1.73 m。所有较短的 mGFR 都在 R-mGFR 的 5%以内,大部分在 2%以内。
这些结果表明,在保留 GFR 的患者中缩短 mGFR 程序可以提供与当前标准相似的结果,同时显著减少程序时间。